https://doi.org/10.4081/aiua.2026.16186
Let us trace our path from glass slide to virtual slide and artificial intelligence
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Accepted: 11 September 2026
Published: 25 September 2026
Beginning in the late 1980s, we developed methods for digital image acquisition, virtual microscopy, and quantitative image analysis that anticipated many features of contemporary digital pathology. Our work included machine vision systems for the automated detection and characterization of high-grade prostatic intraepithelial neoplasia, malignancy-associated changes, and prostate cancer, as well as quantitative approaches for identifying cribriform architecture and early decision support systems for diagnostic pathology. These pioneering studies established methodological foundations that have evolved into modern whole-slide imaging, multiplex tissue analysis, and AI-based diagnostic algorithms. Recent advances in deep learning have further expanded these concepts, improving cancer detection, grading, and prognostic assessment. Although AI has considerable potential to enhance the accuracy and efficiency of prostate pathology, its current role is best viewed as an assistive tool integrated with expert pathological interpretation.
Downloads
1. Bawahab AA. Artificial Intelligence in Equivocal Prostatic Needle Biopsies: Benign Mimics and Cancer Detection. Arch Ital Urol Androl. 2026; 98:15673. DOI: https://doi.org/10.4081/aiua.2026.15673
2. Thompson D, Richards D, Bartels H, et al. Multimegapixel images in histopathology. Anal Quant Cytol Histol 2001; 23:169-77.
3. Montironi R, Cheng L, Lopez-Beltran A, Scarpelli M. Quantitative Image Analysis on Histologic Virtual Slides for Prostate Pathology Diagnosis, Response to Chemopreventive Agents, and Prognosis. Eur Urol Focus. 2017; 3:467-469.
4. Montironi R, Thompson D, Scarpelli M, et al. Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia. J Clin Pathol. 2002; 55:452-460. DOI: https://doi.org/10.1136/jcp.55.6.452
5. Saini ML, Hemmerich A, Banach-Ovens A, et al. Comparison of digital displays for efficient diagnosis and accuracy. J Pathol Inform. 2026; 20:100544. DOI: https://doi.org/10.1016/j.jpi.2026.100544
6. Thompson D, Bartels PH, Bartels HG, Montironi R. Knowledge guided histometry of the basal cell layer in prostatic intraepithelial neoplasia. Anal Quant Cytol Histol 1996; 18:177-84.
7. Montironi R, Thompson D, Scarpelli M, et al. Karyometry detects subvisual differences in chromatin organization state between cribriform and flat high-grade prostatic intraepithelial neoplasia. Mod Pathol 2004; 17:928-37. DOI: https://doi.org/10.1038/modpathol.3800142
8. da Silva VD, Montironi R, Thompson D, et al. Chromatin texture in high grade prostatic intraepithelial neoplasia and early invasive carcinoma. Anal Quant Cytol Histol 1999;21:113-20.
9. Montironi R, Bartels PH, DeCensi A, et al. A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry. Urol Oncol 2013; 31:557-65. DOI: https://doi.org/10.1016/j.urolonc.2011.02.024
10. Montironi R, Diamanti L, Thompson D, et al. Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol 1996; 30:191-200. DOI: https://doi.org/10.1159/000474169
11. Lippolis G, Edsjo¨ A, Helczynski L, et al. Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections. BMC Cancer 2013; 13:408. DOI: https://doi.org/10.1186/1471-2407-13-408
12. Montironi R, Cheng L, Lopez-Beltran A, Scarpelli M. Quantitative Image Analysis on Histologic Virtual Slides for Prostate Pathology Diagnosis, Response to Chemopreventive Agents, and Prognosis. Eur Urol Focus. 2017; 3:467-469. DOI: https://doi.org/10.1016/j.euf.2016.06.013
13. Montironi R, Hamilton PW, Scarpelli M, Thompson D, Bartels PH. Subtle morphological and molecular changes in normal-looking epithelium in prostates with prostatic intraepithelial neoplasia or cancer. Eur Urol 1999; 35:468-73. DOI: https://doi.org/10.1159/000019881
14. Montironi R, Filho AL, Santinelli A, et al. Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. Virchows Arch 2000; 437:625-34. DOI: https://doi.org/10.1007/s004280000290
15. Lee G, Veltri RW, Ali Set al. Nuclear shape and architecture in benign fields predict biochemical recurrence in prostate cancer patients following radical prostatectomy. Eur Urol Focus. 2017; 3:457-466. DOI: https://doi.org/10.1016/j.euf.2016.05.009
16. Montironi R, Cimadamore A, Massari F, et al. Whole Slide Imaging of Large Format Histology in Prostate Pathology: Potential for Information Fusion. Arch Pathol Lab Med. 2017; 141:1460-1461. DOI: https://doi.org/10.5858/arpa.2017-0198-LE
17. Bartels PH, Bartels HG, Montironi R, et al. Machine vision in the detection of prostate lesions in histologic sections. Anal Quant Cytol Histol. 1998; 20:358-64.
18. Pantanowitz L, Quiroga-Garza GM, Bien L, et al. An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study. Lancet Digit Health. 2020; 2:e407-e416. DOI: https://doi.org/10.1016/S2589-7500(20)30159-X
19. Montironi R, Cimadamore A, Scarpelli M, et al. Let us not forget about our past contributions to the field of prostatic neoplasms: To some extent what we value now was already there. Pathol Res Pract. 2021; 219:153377. DOI: https://doi.org/10.1016/j.prp.2021.153377
20. Bartels PH, Thompson D, Bartels HG, et al. Machine visionbased histometry of premalignant and malignant prostatic lesions. Pathol Res Pract. 1995; 191:935-44. DOI: https://doi.org/10.1016/S0344-0338(11)80979-9
21. Thompson D, Bartels PH, Bartels HG, Montironi R. Image segmentation of cribriform gland tissue. Anal Quant Cytol Histol. 1995;17:314-22.
22. Montironi R, Cimadamore A, Gasparrini S, et al. Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma. Expert Rev Anticancer Ther. 2018; 18:685-693. DOI: https://doi.org/10.1080/14737140.2018.1469406
23. Ambrosini P, Hollemans E, Kweldam CF, et al. Automated detection of cribriform growth patterns in prostate histology images. Sci Rep. 2020; 10:14904. DOI: https://doi.org/10.1038/s41598-020-71942-7
24. Bartels PH, Thompson D, Montironi R, et al. Diagnostic decision support for prostate lesions. Pathol Res Pract. 1995; 191:945-57. DOI: https://doi.org/10.1016/S0344-0338(11)80980-5
25. Montironi R, Cheng L, Lopez-Beltran A, et al. Decision support systems for morphology-based diagnosis and prognosis of prostate neoplasms: a methodological approach. Cancer. 2009; 115(13Suppl):3068-77. DOI: https://doi.org/10.1002/cncr.24345
26. Goldenberg SL, Nir G, Salcudean SE. A new era: artificial intelligence and machine learning in prostate cancer. Nat Rev Urol. 2019;16:391-403. DOI: https://doi.org/10.1038/s41585-019-0193-3
27. Thenault R, Kaulanjan K, Darde T, et al. The application of artificial intelligence in prostate cancer management—what improvements can be expected? A systematic review. Appl Sci. 2020;10:6428. DOI: https://doi.org/10.3390/app10186428
28. Cimadamore A, Lopez-Beltran A, Scarpelli M, et al. Artificial intelligence and prostate cancer: Advances and challenges. Urologia. 2022; 89:388-390. DOI: https://doi.org/10.1177/03915603211062409
Ethics Approval
CRediT authorship contribution
AC, AT and RM original drafting of the manuscript
Data Availability Statement
Not applicable
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.